Tivicay

Product NDC
67296-1818
11-digit product format
672961818
Labeler code
67296
Product ID
67296-1818_b0016570-7e04-02f6-e053-2995a90a95b4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dolutegravir sodium
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
RedPharm Drug, Inc.
Application
NDA204790
Marketing category
NDA
Marketing start
2013-08-13
Marketing end
0000-00-00
Substance
DOLUTEGRAVIR SODIUM
Active strength
50 mg/1
Pharmacologic classes
HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3832141c-c294-474a-9473-1052c891450eProduct name220230105
3644e9cf-6f4d-4b63-b875-6a4b5187c47eProduct name120190703
44633898-5724-4273-abcc-3541a1107946Product name120180124
7d3f81af-5024-0cff-2664-d433b7688444Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
67296-1818-32024-07-18C16284748780-1d6a99b39-e2dc-a426-e053-dadaa90af4c2Tivicay 50mg tab
67296-1818-32022-01-28C16284748780-1d6a99b39-e2dc-a426-e053-dadaa90af4c2Tivicay 50mg tab

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67296-1818-3Tivicay3 in 1 BOTTLETABLET, FILM COATED35
67296-1818-5Tivicay5 in 1 BOTTLETABLET, FILM COATED55
67296-1818-7Tivicay28 in 1 BOTTLETABLET, FILM COATED285

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67296-1818TIVICAY (DOLUTEGRAVIR SODIUM) TABLET, FILM COATED [REDPHARM DRUG, INC.]5Legacy NDC, 3 package rows20240719_b00132b8-58b1-7533-e053-2995a90a0cf1.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1433873dolutegravir 50 MG Oral TabletPSNb00132b8-58b1-7533-e053-2995a90a0cf15
1433879Tivicay 50 MG Oral TabletPSNb00132b8-58b1-7533-e053-2995a90a0cf15
1433879dolutegravir 50 MG Oral Tablet [Tivicay]SBDb00132b8-58b1-7533-e053-2995a90a0cf15
1433873dolutegravir 50 MG Oral TabletSCDb00132b8-58b1-7533-e053-2995a90a0cf15
1433873dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral TabletSYb00132b8-58b1-7533-e053-2995a90a0cf15
1433879Tivicay 50 MG (as dolutegravir sodium) Oral TabletSYb00132b8-58b1-7533-e053-2995a90a0cf15
1433879Tivicay 50 MG Oral TabletSYb00132b8-58b1-7533-e053-2995a90a0cf15

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
67296-1818-3672961818033 TABLET, FILM COATED in 1 BOTTLE (67296-1818-3) 2013-08-130000-00-00NoNoCurrent
67296-1818-5672961818055 in 1 BOTTLEHistorical
67296-1818-76729618180728 in 1 BOTTLEHistorical